• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer.

作者信息

Pizzocaro G, Salvioni R, Zanoni F

出版信息

J Urol. 1985 Sep;134(3):485-9. doi: 10.1016/s0022-5347(17)47252-1.

DOI:10.1016/s0022-5347(17)47252-1
PMID:2993672
Abstract

Bilateral retroperitoneal lymphadenectomy is mainly a staging procedure in patients with stage I nonseminomatous testis cancer, and it causes permanent loss of antegrade ejaculation in approximately two-thirds of the cases. Between May 1978 and August 1981, 61 consecutive patients with no intraoperative evidence of lymph node involvement underwent unilateral retroperitoneal lymph-adenectomy for nonseminomatous germinal testis tumors. Microscopic metastases were found in 1 to 4 retroperitoneal nodes in 6 cases (9.8 per cent). Antegrade ejaculation was absent postoperatively in 11 patients (18 per cent), with no significant difference between patients who underwent lymph node dissection on the left or right side. Ejaculation returned spontaneously in 3 patients, 1 of whom fathered a child. The disease recurred in 10 patients 3 to 35 months after lymphadenectomy (median 6 months). Disease recurred in 8 of 55 patients (14.5 per cent) with negative nodes and 2 of 6 (33.3 per cent) with positive histological findings. No patient suffered retroperitoneal recurrence. The more than 3-year survival rates free of disease were 96.4 and 83.3 per cent in patients with pathological stages I and II disease, respectively. Unilateral retroperitoneal lymphadenectomy in patients with intraoperative stage I nonseminomatous germinal testis cancer preserves antegrade ejaculation in more than 80 per cent of the cases without apparently compromising the long-term survival.

摘要

相似文献

1
Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer.
J Urol. 1985 Sep;134(3):485-9. doi: 10.1016/s0022-5347(17)47252-1.
2
Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.一项针对睾丸临床I期非精原细胞性生殖细胞肿瘤省略腹膜后淋巴结清扫术的监测研究的困难之处。
J Urol. 1987 Dec;138(6):1393-6. doi: 10.1016/s0022-5347(17)43652-4.
3
Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy.
J Urol. 1990 Nov;144(5):1160-3. doi: 10.1016/s0022-5347(17)39681-7.
4
[Nerve sparing retroperitoneal lymphadenectomy with intraoperative electrostimulation in patients with nonseminomatous testicular tumors].
Urologe A. 1992 Jan;31(1):1-7.
5
Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation.1965年至1989年临床分期为A期睾丸癌的腹膜后淋巴结清扫术:技术改进及其对射精功能的影响
J Urol. 1993 Feb;149(2):237-43. doi: 10.1016/s0022-5347(17)36046-9.
6
Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.睾丸临床I期非精原细胞性生殖细胞肿瘤保留神经的腹膜后淋巴结清扫术的并发症:德国睾丸癌研究组的经验
J Urol. 2003 May;169(5):1710-4. doi: 10.1097/01.ju.0000060960.18092.54.
7
Preservation of ejaculation through a modified retroperitoneal lymph node dissection in low stage testis cancer.通过改良腹膜后淋巴结清扫术保留低分期睾丸癌患者的射精功能。
J Urol. 1993 Jun;149(6):1472-4. doi: 10.1016/s0022-5347(17)36418-2.
8
Retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germinal testis cancer.
Eur J Surg Oncol. 1986 Mar;12(1):25-8.
9
What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?在患有 II 期或 III 期疾病的非精原细胞瘤生殖细胞肿瘤患者中,单独进行淋巴结肿大切除术的作用是什么?
Clin Genitourin Cancer. 2012 Sep;10(3):185-9. doi: 10.1016/j.clgc.2012.04.002. Epub 2012 Jun 7.
10
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.腹腔镜腹膜后淋巴结清扫术治疗临床Ⅰ期睾丸非精原细胞瘤生殖细胞肿瘤:大容量中心的安全性和疗效分析。
J Urol. 2018 Mar;199(3):741-747. doi: 10.1016/j.juro.2017.09.088. Epub 2017 Sep 28.

引用本文的文献

1
A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor.机器人辅助腹膜后淋巴结清扫术治疗非精原细胞瘤生殖细胞肿瘤后生殖结局的综合评估。
Asian J Androl. 2022 Nov-Dec;24(6):579-583. doi: 10.4103/aja2021132.
2
The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor.改良模板在早期和晚期非精原细胞性生殖细胞肿瘤中的应用
Adv Urol. 2018 Apr 5;2018:6783147. doi: 10.1155/2018/6783147. eCollection 2018.
3
Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.
改良模板的批判性评价及腹膜后淋巴结清扫术的当前趋势。
Curr Urol Rep. 2013 Oct;14(5):511-7. doi: 10.1007/s11934-013-0366-1.
4
The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates.改良腹膜后淋巴结清扫模板的演变、争议及潜在陷阱
World J Urol. 2009 Aug;27(4):477-83. doi: 10.1007/s00345-009-0407-z. Epub 2009 Apr 11.
5
Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer.保留射精功能用于转移性睾丸癌患者化疗后行保留神经的腹膜后淋巴结清扫术时。
Urology. 2009 Feb;73(2):328-31; discussion 331-2. doi: 10.1016/j.urology.2008.08.501. Epub 2008 Nov 20.
6
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection.化疗后腹膜后淋巴结清扫术的睾丸癌患者的射精情况
Br J Cancer. 1999 Apr;80(1-2):249-55. doi: 10.1038/sj.bjc.6690347.
7
Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.临床I期非精原细胞瘤性睾丸肿瘤管理中的成本与风险效益考量
Ann Surg Oncol. 1996 Jan;3(1):86-93. doi: 10.1007/BF02409057.
8
Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis.
World J Urol. 1994;12(3):113-9. doi: 10.1007/BF00192265.